OMG!!! Banana try to keep up!!!!! I posted that info here at least a dozen times...there was nothing wrong with past versions...fact is they didn't sell anywhere they were shipped.They didn't repeat order....Walmart did but not enough to keep shelf space.THEY GOT DELISTED.
rEAD bELOW...DOESN'T IT SOUND LIKE ALL SYSTEMS GO???
"Our US distributor, Dr. Fresh, reports that a number of Wal-Mart locations have sold out of product, and we have recently completed a shipment to fill shelves. The product was sent by air to ensure prompt delivery"
Our US distributor Dr. Fresh continues to play an important role in developing sales. Dr. Fresh has earned 3.0 million restricted shares to date, and can earn an additional 2.0 million based on Flushaway(TM) being placed on additional Tier 1 retail outlets and upon meeting specified sales targets. In order to protect competitive positions, the details of this arrangement must remain confidential.
DR.FRESH IS NO SMALL PLAYER...IF THERE WAS A PROBLEM HE WOULD NO GET INVOLVED,THEY NOR WALMART WOULD NOT GET INVOLVED WITH PROBLEM PRODUCTS...EVER HEAR OF LAWSUITS????
Were they competitivly priced? Were they confortable and did what was expected of pads and liners and flushed away with no problem at all?
ONCE AGAIN!!! HERE IS PROOF
First, the product has been dramatically improved. Product quality now far sur- BETTER THAN GREEN APPEAL FINANCIAL Profile passes that of previous generation Flushaways. Initial consumer testing reports high levels of satisfaction. CES is now undertaking focus group initiatives using a third party research firm with the first round of results expected within sixty days or so. The company has also re-styled its packaging. The new package features a more vibrant color scheme including metallic silver and embossing. Over all, the new packing looks more attractive and invites consumers to reach for the product on the shelf. As for pricing, CES has also reformulated t
In the past year, and especially in the past six months, CES has almost completely revised its corporate structure and operating plans to make it a much more competitive player in the massive fem-hy market. With shares now consolidated in the $0.10 range and the new business plan going into motion, the time to get back into CES and or add to existing positions would seem right.
In fact, never in the company’s history have there been so many strong positive developments on the horizon. Never has the upside for CES looked so attractive. Making it to market Last year, the company got
Market Data 
Markets 
AI
